Skip to content

2026 Publications

  • Käs F, Elhai M, Becker MO, Dobrota R, Mihai C, Sauer G, Tofani L, Bečvář R, Rednic S, Carreira PE, Kumánovics G, Airò P, Mueller-Ladner U, Del Galdo F, Ramazan AM, Martin M, Simeón-Aznar CP, Parvu M, Del Papa N, Hoffmann-Vold AM, Distler O, Bruni C; EUSTAR collaborators. Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database. J Autoimmun. 2026 May;160:103555. doi: 10.1016/j.jaut.2026.103555. Epub 2026 Apr 20. PMID: 42013635. (PDF)
  • Pecher AC, Boubaya M, Allanore Y, Smith V, de Vries-Bouwstra J, Bečvář R, Moroncini G, Launay D, De Santis M, Solanki K, Montecucco C, Idolazzi L, Nihal F, Przemyslaw K, Truchetet ME, Kuwana M, Del Gado F, Distler O, Elhai M, Henes J. Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score. Ann Rheum Dis. 2026 Mar 16:S0003-4967(26)00065-8. doi: 10.1016/j.ard.2026.01.016. Epub ahead of print. PMID: 41846198. (PDF)
  • Moschetti L, Rovaris S, Bonomi F, Codes-Mendez H, Martín-López M, Cacciapaglia F, Tonutti A, Galdo FD, Campochiaro C, Truchetet ME, Allanore Y, Kuwana M, Bruni C, Santos CS, Moroncini G, Caetano J, Granel B, Groseanu L, Pedretti E, Colombo E, Guerini M, Pereira Silva M, Bearzi P, Belloli L, Alegre-Sancho JJ, Maglio C, Cuomo G, Parvu M, Poormoghim H, Idolazzi L, Andréasson K, De Santis M, Iannone F, Carreira PE, Castellví I, Guiducci S, Cavazzana I, Franceschini F, Airò P, Lazzaroni MG. The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort. Ther Adv Musculoskelet Dis. 2026 Mar 2;18:1759720X261422369. doi: 10.1177/1759720X261422369. PMID: 41782907; PMCID: PMC12953999. (PDF)
  • Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, Elhai M, Jordan S, Hachulla E, Müller-Ladner U, Siegert E, Allanore Y, Riemekasten G, Bergmann C, Becvar R, Solanki K, Anic B, Szabo I, Stamenkovic B, Distler J, Carreira PE, Cuomo G, Castellví I, Balbir-Gurman A, Airò P, Litinsky I, Saketkoo LA, Bertaccini B, Vonk MC, de Vries-Bouwstra J, Hoffmann-Vold AM, Matucci-Cerinic M, Distler O, Bruni C; EUSTAR collaborators. The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133). Ann Rheum Dis. 2026 Jan 17:S0003-4967(25)04602-3. doi: 10.1016/j.ard.2025.12.008. Epub ahead of print. PMID: 41549016. (PDF)
  • Campochiaro C, Truchetet ME, Vonk M, De Luca G, Cuomo G, Ananieva LP, Hachulla E, Smith V, Gheorghiu AM, Becvar R, Carreira P, Hunzelmann N, Furst DE, Ortiz-Santamaria V, Del Galdo F, Matucci-Cerinic M, Hoffmann-Vold AM; EUSTAR collaborators. Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database. Arthritis Rheumatol. 2026 Jan 22. doi: 10.1002/art.70043. Epub ahead of print. PMID: 41568546. (PDF)